Page 9 - BRIPeBook2021
P. 9

Proteolytic markers associated with kidney disease in HIV positive


 individuals before initiation of anti-retroviral therapy (ART)


 CB Mahachi , KH Myburgh , WD Bates , RM Moosa 4
 1,2
             3
  2
 1 Physiology Unit, Department of Biomedical Sciences, University of Zimbabwe, P.O Box MP 167 Mount Pleasant, Harare, Zimbabwe
 2 Department of Physiological Sciences, Stellenbosch University, Private Bag X1, Matieland, Stellenbosch, 7602, South Africa.
 3 Division of Anatomical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University and National
 Health Laboratory Service, Cape Town, South Africa
 4 Division of Nephrology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

 Background                                         Discussion and Conclusion
 Tissue destruction contributes to chronic kidney disease progression with proteolytic enzymes, neutrophil gelatinase (NGAL) and matrix   • NGAL and MMP-9 were higher in plasma
 metalloproteinase-9 (MMP-9), playing individual and interactive roles. When  MMP-9 is complexed to  than urine, even when expressed relative
 NGAL , this enables the activity of MMP-9 by inhibiting it inactivation  to Creatinine
 Objective                                         • HIVAN participants formed more
                                                     complex than HIV-NKD in urine
 To determine if NGAL and MMP-9 in urine or plasma differentiate between different forms of  • The more severe the renal disease the
 kidney diseases in patients with treatment naïve human immunodeficiency virus (HIV) infection   higher the NGAL in urine and plasma
 (HIV ) to those with focal segmental glomerulosclerosis and no HIV infection and if the complex fails to   • Plasma MMP9 and MMP9-NGAL complex
 +
 differentiate whether measured in urine or plasma.  were not statistically significant different
                                                     between the groups
                                                                References
 Results  Results
 Material & Methods   NGAL: Plasma NGAL was significantly   1. Xiang D, Zhang H, Bai J, Ma J, Li M, Gao J, et al.
                                                      Clinical application of neutrophil gelatinase-
 36 participants (25% male) participated were   higher in HIVAN compared to other groups   associated lipocalin in the revised chronic kidney
 recruited from Tygerberg Hospital Renal Clinic   at p<0.05.   disease classification. Int J Clin Exp Pathol.
                                                      2014;7(10):7172–81.
 and OI Clinic, :   Urine NGAL (ng/mg) was significant   2. Moriya, H., Mochida, Y., Ishioka, K. et al. Plasma
 10 HIV controls, no kidney disease (HIV-  different in   neutrophil gelatinase-associated lipocalin (NGAL) is
 +
 NKD), 10 HIV-associated nephropathy   • HIVAN compared to HIV-NKD at p<0.01   an indicator of interstitial damage and a predictor of
 (HIVAN), 6 HIV focal segmental   • HIVAN and HIV-FSGS at p<0.05.   kidney function worsening of chronic kidney disease
 glomerulosclerosis (HIV-FSGS) and 10 FSGS no         in the early stage: a pilot study. Clin Exp
 HIV (KD-FSGS). HIVAN and FSGS features   MMP-9: Urine MMP-9 (ng/mg) differed   Nephrol 21, 1053–1059 (2017).
 were established on histology of biopsied renal   significantly between HIVAN and HIV-NKD
 tissue. Urine and plasma free NGAL, free   at p<0.05.
 MMP-9 and MMP-9/NGAL-complex were
 analysed using enzyme-linked immunosorbent   MMP-9/NGAL-complex: Urine MMP-9/NGAL-
 assay and normalized to urine creatinine and   complex (ng.mg) was significantly higher in
 expressed as ng/mg.  HIVAN compared to HIV-NKD at p<0.05.
   4   5   6   7   8   9   10   11   12   13   14